Skip to main content
Erschienen in: Supportive Care in Cancer 2/2009

01.02.2009 | Original Article

Can anorexia predict patient satisfaction with quality of life in advanced cancer?

verfasst von: Christopher G. Lis, Digant Gupta, James F. Grutsch

Erschienen in: Supportive Care in Cancer | Ausgabe 2/2009

Einloggen, um Zugang zu erhalten

Abstract

Goals

Anorexia is the second most common symptom after fatigue in patients with advanced cancer. We quantified the relationship between anorexia and patient satisfaction with quality of life (QoL) in advanced cancer.

Materials and methods

A case series of 954 cancer patients treated at the Cancer Treatment Centers of America. Anorexia was measured using the QLQ-C30 loss of appetite/anorexia subscale. Patient satisfaction with QoL was measured using the Ferrans and Powers Quality of Life Index (QLI). The relationship between anorexia and QLI was evaluated using multivariate analysis of variance and multiple regression analysis.

Main results

Of 954 patients, 579 were females and 375 males with the median age at presentation of 56 years. Of these patients, 66% had failed prior treatment. Most common cancers were breast (26%), colorectal (19%), and lung (16%). After controlling for the effects of age, treatment history, and other QLQ-C30 symptom subscales, every 10 unit increase in anorexia was statistically significantly associated with 0.18 unit decline in QLI health and physical function score.

Conclusion

We found that anorexia is significantly correlated with patient satisfaction with health and physical function in advanced cancer. Future studies should evaluate the impact of integrative cancer care services on patient satisfaction with QoL.
Literatur
1.
Zurück zum Zitat Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef Aaronson NK, Ahmedzai S, Bergman B et al (1993) The European Organization for Research and Treatment of Cancer QLQ-C30: a quality-of-life instrument for use in international clinical trials in oncology. J Natl Cancer Inst 85(5):365–376PubMedCrossRef
2.
Zurück zum Zitat Cella DF, Bonomi AE (1995) Measuring quality of life: 1995 update. Oncology (Williston Park) 9(11 Suppl):47–60 Cella DF, Bonomi AE (1995) Measuring quality of life: 1995 update. Oncology (Williston Park) 9(11 Suppl):47–60
3.
Zurück zum Zitat Chang VT, Xia Q, Kasimis B (2005) The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed Chang VT, Xia Q, Kasimis B (2005) The Functional Assessment of Anorexia/Cachexia Therapy (FAACT) appetite scale in veteran cancer patients. J Support Oncol 3(5):377–382PubMed
4.
Zurück zum Zitat Davis MP, Dickerson D (2000) Cachexia and anorexia: cancer’s covert killer. Support Care Cancer 8(3):180–187PubMedCrossRef Davis MP, Dickerson D (2000) Cachexia and anorexia: cancer’s covert killer. Support Care Cancer 8(3):180–187PubMedCrossRef
5.
Zurück zum Zitat Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed Ferrans CE (1990) Development of a quality of life index for patients with cancer. Oncol Nurs Forum 17(3 Suppl):15–19PubMed
6.
Zurück zum Zitat Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed Ferrans CE (1996) Development of a conceptual model of quality of life. Sch Inq Nurs Pract 10(3):293–304PubMed
7.
Zurück zum Zitat Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed Ferrans CE, Powers MJ (1985) Quality of life index: development and psychometric properties. ANS Adv Nurs Sci 8(1):15–24PubMed
8.
Zurück zum Zitat Ferrans CE, Powers MJ (1992) Psychometric assessment of the quality of life index. Res Nurs Health 15(1):29–38PubMedCrossRef Ferrans CE, Powers MJ (1992) Psychometric assessment of the quality of life index. Res Nurs Health 15(1):29–38PubMedCrossRef
9.
Zurück zum Zitat Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient–observer agreement. J Clin Epidemiol 50(4):441–450PubMedCrossRef Groenvold M, Klee MC, Sprangers MA, Aaronson NK (1997) Validation of the EORTC QLQ-C30 quality of life questionnaire through combined qualitative and quantitative assessment of patient–observer agreement. J Clin Epidemiol 50(4):441–450PubMedCrossRef
10.
Zurück zum Zitat Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. J Clin Oncol 13(5):1249–1254PubMed Hjermstad MJ, Fossa SD, Bjordal K, Kaasa S (1995) Test/retest study of the European organization for research and treatment of cancer core quality-of-life questionnaire. J Clin Oncol 13(5):1249–1254PubMed
11.
Zurück zum Zitat Jacobsen PB, Weitzner MA (1999) Evaluation of palliative endpoints in oncology clinical trials. Cancer Control 6(5):471–477PubMed Jacobsen PB, Weitzner MA (1999) Evaluation of palliative endpoints in oncology clinical trials. Cancer Control 6(5):471–477PubMed
12.
Zurück zum Zitat Lagman RL, Davis MP, LeGrand SB, Walsh D (2005) Common symptoms in advanced cancer. Surg Clin North Am 85(2):237–255PubMedCrossRef Lagman RL, Davis MP, LeGrand SB, Walsh D (2005) Common symptoms in advanced cancer. Surg Clin North Am 85(2):237–255PubMedCrossRef
13.
Zurück zum Zitat Laviano A, Meguid MM, Inui A et al (2005) Therapy insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2(3):158–165PubMedCrossRef Laviano A, Meguid MM, Inui A et al (2005) Therapy insight: cancer anorexia–cachexia syndrome—when all you can eat is yourself. Nat Clin Pract Oncol 2(3):158–165PubMedCrossRef
14.
Zurück zum Zitat Laviano A, Meguid MM, Rossi-Fanelli F (2003) Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 4(11):686–694PubMedCrossRef Laviano A, Meguid MM, Rossi-Fanelli F (2003) Cancer anorexia: clinical implications, pathogenesis, and therapeutic strategies. Lancet Oncol 4(11):686–694PubMedCrossRef
15.
Zurück zum Zitat Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 17(4):240–247PubMedCrossRef Maltoni M, Nanni O, Pirovano M et al (1999) Successful validation of the palliative prognostic score in terminally ill cancer patients. Italian Multicenter Study Group on Palliative Care. J Pain Symptom Manage 17(4):240–247PubMedCrossRef
16.
Zurück zum Zitat McClement S (2005) Cancer anorexia–cachexia syndrome: psychological effect on the patient and family. J Wound Ostomy Continence Nurs 32(4):264–268PubMed McClement S (2005) Cancer anorexia–cachexia syndrome: psychological effect on the patient and family. J Wound Ostomy Continence Nurs 32(4):264–268PubMed
17.
Zurück zum Zitat Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12(3):608–616PubMed Osoba D (1994) Lessons learned from measuring health-related quality of life in oncology. J Clin Oncol 12(3):608–616PubMed
18.
Zurück zum Zitat Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed Osoba D, Rodrigues G, Myles J et al (1998) Interpreting the significance of changes in health-related quality-of-life scores. J Clin Oncol 16(1):139–144PubMed
19.
Zurück zum Zitat Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17(4):231–239PubMedCrossRef Pirovano M, Maltoni M, Nanni O et al (1999) A new palliative prognostic score: a first step for the staging of terminally ill cancer patients. Italian Multicenter and Study Group on Palliative Care. J Pain Symptom Manage 17(4):231–239PubMedCrossRef
20.
Zurück zum Zitat Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef Walsh D, Rybicki L (2006) Symptom clustering in advanced cancer. Support Care Cancer 14(8):831–836PubMedCrossRef
Metadaten
Titel
Can anorexia predict patient satisfaction with quality of life in advanced cancer?
verfasst von
Christopher G. Lis
Digant Gupta
James F. Grutsch
Publikationsdatum
01.02.2009
Verlag
Springer-Verlag
Erschienen in
Supportive Care in Cancer / Ausgabe 2/2009
Print ISSN: 0941-4355
Elektronische ISSN: 1433-7339
DOI
https://doi.org/10.1007/s00520-008-0447-8

Weitere Artikel der Ausgabe 2/2009

Supportive Care in Cancer 2/2009 Zur Ausgabe

Alphablocker schützt vor Miktionsproblemen nach der Biopsie

16.05.2024 alpha-1-Rezeptorantagonisten Nachrichten

Nach einer Prostatabiopsie treten häufig Probleme beim Wasserlassen auf. Ob sich das durch den periinterventionellen Einsatz von Alphablockern verhindern lässt, haben australische Mediziner im Zuge einer Metaanalyse untersucht.

Antikörper-Wirkstoff-Konjugat hält solide Tumoren in Schach

16.05.2024 Zielgerichtete Therapie Nachrichten

Trastuzumab deruxtecan scheint auch jenseits von Lungenkrebs gut gegen solide Tumoren mit HER2-Mutationen zu wirken. Dafür sprechen die Daten einer offenen Pan-Tumor-Studie.

Mammakarzinom: Senken Statine das krebsbedingte Sterberisiko?

15.05.2024 Mammakarzinom Nachrichten

Frauen mit lokalem oder metastasiertem Brustkrebs, die Statine einnehmen, haben eine niedrigere krebsspezifische Mortalität als Patientinnen, die dies nicht tun, legen neue Daten aus den USA nahe.

Labor, CT-Anthropometrie zeigen Risiko für Pankreaskrebs

13.05.2024 Pankreaskarzinom Nachrichten

Gerade bei aggressiven Malignomen wie dem duktalen Adenokarzinom des Pankreas könnte Früherkennung die Therapiechancen verbessern. Noch jedoch klafft hier eine Lücke. Ein Studienteam hat einen Weg gesucht, sie zu schließen.

Update Onkologie

Bestellen Sie unseren Fach-Newsletter und bleiben Sie gut informiert.